Proteinuria in CKD Progression: Understanding Its Role and Monitoring Strategies
Clinician's RoundtableProteinuria in CKD Progression: Understanding Its Role and Monitoring Strategies
Deciphering the Link: Proteinuria and eGFR Dynamics in IgAN and FSGS
Clinician's RoundtableDeciphering the Link: Proteinuria and eGFR Dynamics in IgAN and FSGS
Navigating Treatment Goals in IgAN: The Impact of ET-1 and Ang II
Clinician's RoundtableNavigating Treatment Goals in IgAN: The Impact of ET-1 and Ang II
Enhancing IgAN Care: The Importance of a Proactive Approach
Clinician's RoundtableEnhancing IgAN Care: The Importance of a Proactive Approach
Uncovering New Biomarkers for RCC: A Review of Emerging Techniques
Project Oncology®Uncovering New Biomarkers for RCC: A Review of Emerging Techniques
The Potential Impact of RCC Molecular Subtypes on Treatment Outcomes
Project Oncology®The Potential Impact of RCC Molecular Subtypes on Treatment Outcomes
Episode 1 Part A: Signs and Symptoms of CKD and T2D
MinuteCE®Episode 1 Part A: Signs and Symptoms of CKD and T2D
Episode 1 Part B: Diagnosis, Monitoring, and Risk Assessment
MinuteCE®Episode 1 Part B: Diagnosis, Monitoring, and Risk Assessment
Episode 2 Part A: The “High Risk” Patient: What Providers Need to Know
MinuteCE®Episode 2 Part A: The “High Risk” Patient: What Providers Need to Know
Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
MinuteCE®Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D
MinuteCE®Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D
Managing Lupus Nephritis: Multidisciplinary Insights on Recent Guideline Updates
Medical Industry FeatureManaging Lupus Nephritis: Multidisciplinary Insights on Recent Guideline Updates
Early Kidney Stress Signals: Risk Assessment Imperatives
Medical Industry FeatureEarly Kidney Stress Signals: Risk Assessment Imperatives
IgAN Insights: The Potential Role of the Complement System in Disease Progression
Medical Industry FeatureIgAN Insights: The Potential Role of the Complement System in Disease Progression
Identifying Patients at High-Risk for IgAN Progression: Key Factors to Know
Medical Industry FeatureIdentifying Patients at High-Risk for IgAN Progression: Key Factors to Know
How the HIF Pathway Orchestrates an Adaptive, Physiological Response to Anemia
Medical Industry FeatureHow the HIF Pathway Orchestrates an Adaptive, Physiological Response to Anemia
Advancing the Science of Anemia Due to CKD
Medical Industry FeatureAdvancing the Science of Anemia Due to CKD
drugs.com
09/10/2024- finance.yahoo.com
09/10/2024
- medicalnewstoday.com
09/09/2024
- medicalxpress.com
09/04/2024
- nyulangone.org
09/04/2024
- news.ki.se
08/28/2024
